| Profit & Loss |
| Date of Accounts |
2019-09-30 | 2020-09-30 |
| Currency |
| |
|
| Balance Sheet |
| Cash Bank On Hand | 840 195 | 1 823 912 |
| Current Assets | 5 473 519 | 5 234 776 |
| Debtors | 4 629 214 | 3 186 945 |
| Net Assets Liabilities | 1 798 826 | 1 123 715 |
| Other Debtors | 12 855 | 6 310 |
| Property Plant Equipment | 37 199 | 30 319 |
| Total Inventories | 4 110 | 223 919 |
|
| Other Financial Data |
| Audit Fees Expenses | 4 400 | 4 535 |
| Other Non-audit Services Fees | 5 902 | 1 860 |
| Accumulated Depreciation Impairment Property Plant Equipment | 44 582 | 51 462 |
| Administration Support Average Number Employees | 9 | 10 |
| Administrative Expenses | 7 926 664 | 9 027 713 |
| Amounts Owed By Related Parties | 200 166 | 307 651 |
| Applicable Tax Rate | 19 | 19 |
| Average Number Employees During Period | 71 | 79 |
| Balances With Banks | 839 981 | 1 823 503 |
| Cash Cash Equivalents | 840 195 | 1 823 912 |
| Cash Cash Equivalents Cash Flow Value | 840 195 | |
| Cash On Hand | 214 | 409 |
| Comprehensive Income Expense | 1 573 969 | 1 324 889 |
| Creditors | 3 704 824 | 4 135 619 |
| Current Tax For Period | 333 708 | 280 185 |
| Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences | 379 | -1 307 |
| Deferred Tax Liabilities | 7 068 | 5 761 |
| Depreciation Amortisation Expense | 8 270 | 6 880 |
| Depreciation Expense Property Plant Equipment | 8 270 | 6 880 |
| Dividend Per Share Interim | 2 | 2 |
| Dividends Paid | -1 500 000 | -2 000 000 |
| Dividends Paid Classified As Financing Activities | -1 500 000 | -2 000 000 |
| Dividends Paid On Shares Interim | 1 500 000 | 2 000 000 |
| Financial Assets | 5 340 361 | 4 855 545 |
| Financial Liabilities | 181 832 | 157 959 |
| Further Item Cash Flow From Used In Operating Activities Component Total Net Cash Flows From Used In Operating Activities | 43 663 | |
| Future Minimum Lease Payments Under Non-cancellable Operating Leases | 179 917 | 52 917 |
| Gain Loss In Cash Flows From Change In Creditors Trade Other Payables | -129 035 | -364 318 |
| Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables | 1 441 348 | -1 442 269 |
| Gain Loss In Cash Flows From Change In Inventories | -148 034 | 219 809 |
| Gross Profit Loss | 9 827 112 | 10 628 149 |
| Income Taxes Paid Refund Classified As Operating Activities | 220 731 | 213 708 |
| Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation | -937 051 | 983 717 |
| Increase Decrease In Existing Provisions | | -1 307 |
| Increase From Depreciation Charge For Year Property Plant Equipment | | 6 880 |
| Interest Income On Bank Deposits | 7 143 | 3 166 |
| Interest Payable Similar Charges Finance Costs | -465 | -165 |
| Interest Received Classified As Investing Activities | 7 143 | 3 166 |
| Interest Received Classified As Operating Activities | 7 143 | 3 166 |
| Loss On Financing Activities Due To Foreign Exchange Differences | -465 | -165 |
| Minimum Operating Lease Payments Recognised As Expense | 127 000 | 127 000 |
| Net Cash Flows From Used In Financing Activities | -1 499 998 | -2 000 000 |
| Net Cash Flows From Used In Investing Activities | -4 889 | 3 166 |
| Net Cash Flows From Used In Operating Activities | 567 836 | 2 980 551 |
| Net Cash Generated From Operations | 788 567 | 3 194 259 |
| Net Cash Inflow Outflow From Operations Before Movements In Working Capital | 1 952 846 | 1 607 481 |
| Net Current Assets Liabilities | 1 768 695 | 1 099 157 |
| Number Equity Instruments Exercised Share-based Payment Arrangement | 14 197 | 13 517 |
| Number Equity Instruments Expired Share-based Payment Arrangement | 225 | 212 |
| Number Equity Instruments Forfeited Share-based Payment Arrangement | | 371 |
| Number Equity Instruments Granted Share-based Payment Arrangement | 21 300 | |
| Number Equity Instruments Outstanding Share-based Payment Arrangement | 112 131 | 98 455 |
| Number Shares Issued Fully Paid | 1 000 000 | 1 000 000 |
| Other Creditors | 24 433 | 17 230 |
| Other Departments Average Number Employees | 59 | 66 |
| Other Employee Expense | 39 898 | 58 036 |
| Other Interest Receivable Similar Income Finance Income | 7 143 | 3 166 |
| Other Payables Accrued Expenses | 2 557 520 | 3 019 184 |
| Par Value Share | | 0 |
| Pension Costs Defined Contribution Plan | 351 118 | 419 682 |
| Prepayments | 129 048 | 155 312 |
| Proceeds From Issuing Shares | 2 | |
| Profit Loss | 1 573 969 | 1 324 889 |
| Profit Loss On Ordinary Activities Before Tax | 1 908 056 | 1 603 767 |
| Property Plant Equipment Gross Cost | 81 781 | 81 781 |
| Provisions | 7 068 | 5 761 |
| Provisions For Liabilities Balance Sheet Subtotal | 7 068 | 5 761 |
| Purchase Property Plant Equipment | -12 032 | |
| Revenue From Sale Goods | 9 827 112 | 10 628 149 |
| Sales Marketing Distribution Average Number Employees | 3 | 3 |
| Share-based Payment Expense Cash Settled | 43 663 | |
| Social Security Costs | 547 685 | 613 664 |
| Staff Costs Employee Benefits Expense | 5 643 806 | 6 280 002 |
| Taxation Social Security Payable | 751 764 | 678 292 |
| Tax Expense Credit Applicable Tax Rate | 362 531 | 304 716 |
| Tax Increase Decrease From Effect Adjustment In Research Development Tax Credit | -39 600 | -35 419 |
| Tax Increase Decrease From Effect Capital Allowances Depreciation | -715 | 1 307 |
| Tax Increase Decrease From Effect Exercise Employee Share Options | 8 296 | |
| Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss | 3 195 | 9 581 |
| Tax Increase Decrease From Other Short-term Timing Differences | 380 | -1 307 |
| Tax Tax Credit On Profit Or Loss On Ordinary Activities | 334 087 | 278 878 |
| Total Assets Less Current Liabilities | 1 805 894 | 1 129 476 |
| Trade Creditors Trade Payables | 105 322 | 82 087 |
| Trade Debtors Trade Receivables | 4 287 145 | 2 717 672 |
| Turnover Revenue | 9 827 112 | 10 628 149 |
| Unpaid Contributions To Pension Schemes | 52 077 | 58 641 |
| Wages Salaries | 4 661 442 | 5 188 620 |
| Weighted Average Exercise Price Equity Instruments Exercised Share-based Payment Arrangement | 3 | 3 |
| Weighted Average Exercise Price Equity Instruments Expired Share-based Payment Arrangement | 3 | 2 |
| Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement | 5 | |
| Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement | 3 | 3 |
| Work In Progress | 4 110 | 223 919 |
| Company Contributions To Money Purchase Plans Directors | 30 000 | 51 400 |
| Director Remuneration | 726 000 | 762 000 |
(32 pages)